PubMed:8554451 / 406-587
Annnotations
jnlpba-st-training
{"project":"jnlpba-st-training","denotations":[{"id":"T1","span":{"begin":63,"end":80},"obj":"protein"},{"id":"T2","span":{"begin":85,"end":106},"obj":"protein"},{"id":"T3","span":{"begin":125,"end":128},"obj":"protein"},{"id":"T4","span":{"begin":133,"end":142},"obj":"protein"}],"text":"Reactions in comedo carcinomas were significantly negative for estrogen receptor and progesterone receptor, and positive for p53 and HER-2/neu more often than the noncomedo variant."}
genia-medco-coref
{"project":"genia-medco-coref","denotations":[{"id":"C5","span":{"begin":13,"end":30},"obj":"NP"}],"text":"Reactions in comedo carcinomas were significantly negative for estrogen receptor and progesterone receptor, and positive for p53 and HER-2/neu more often than the noncomedo variant."}
GENIAcorpus
{"project":"GENIAcorpus","denotations":[{"id":"T9","span":{"begin":13,"end":30},"obj":"other_name"},{"id":"T10","span":{"begin":63,"end":71},"obj":"lipid"},{"id":"T11","span":{"begin":85,"end":97},"obj":"lipid"},{"id":"T12","span":{"begin":125,"end":128},"obj":"protein_subunit"},{"id":"T13","span":{"begin":133,"end":142},"obj":"protein_molecule"},{"id":"T14","span":{"begin":163,"end":180},"obj":"other_name"}],"text":"Reactions in comedo carcinomas were significantly negative for estrogen receptor and progesterone receptor, and positive for p53 and HER-2/neu more often than the noncomedo variant."}